Sartorius Aktiengesellschaft (BIT:1SRT)

Market Cap	13.29B -10.3%
Revenue (ttm)	3.54B +4.7%
Net Income	154.90M +84.4%
EPS	2.24 +84.2%
Shares Out	n/a
PE Ratio	85.77
Forward PE	35.27
Dividend	0.73 (0.41%)
Ex-Dividend Date	Mar 27, 2026

Volume	n/a
Average Volume	10
Open	n/a
Previous Close	170.67
Day's Range	n/a
52-Week Range	146.20 - 209.50
Beta	n/a
RSI	44.51
Earnings Date	Apr 23, 2026

About BIT:1SRT

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture...

• Industry: Laboratory Analytical Instruments
• Founded: 1870
• Employees: 13,671
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SRT

Financial Performance

In 2025, BIT:1SRT's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.